FDA grants full approval for TIVDAK to treat cervical cancer
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer
Around 7% of the Indian population suffers from IBS
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
Subscribe To Our Newsletter & Stay Updated